Your browser doesn't support javascript.
Validation of Respiratory Rate-Oxygenation Index in Patients With COVID-19-Related Respiratory Failure.
Myers, Laura C; Mark, Dustin; Ley, Brett; Guarnieri, Michael; Hofmeister, Melinda; Paulson, Shirley; Marelich, Gregory; Liu, Vincent X.
  • Myers LC; Division of Research, Kaiser Permanente Northern California, Oakland, CA.
  • Mark D; The Permanente Medical Group, Kaiser Permanente Northern California, Oakland, CA.
  • Ley B; The Permanente Medical Group, Kaiser Permanente Northern California, Oakland, CA.
  • Guarnieri M; The Permanente Medical Group, Kaiser Permanente Northern California, Oakland, CA.
  • Hofmeister M; The Permanente Medical Group, Kaiser Permanente Northern California, Oakland, CA.
  • Paulson S; Respiratory Therapy, Kaiser Permanente Northern California, Oakland, CA.
  • Marelich G; Adult Patient Care Services, Kaiser Permanente Northern California, Oakland, CA.
  • Liu VX; The Permanente Medical Group, Kaiser Permanente Northern California, Oakland, CA.
Crit Care Med ; 50(7): e638-e642, 2022 07 01.
Article in English | MEDLINE | ID: covidwho-1672318
ABSTRACT

OBJECTIVES:

The respiratory rate-oxygenation (ROX) index is a fraction of oxygen saturation, Fio2, and respiratory rate that has been validated to predict receipt of invasive mechanical ventilation in patients receiving high-flow nasal cannula (HFNC). This study aimed to validate ROX in a cohort of inpatients with COVID-19-related respiratory failure.

DESIGN:

Retrospective validation of the ROX index. We calculated sensitivity, specificity, positive predictive value, negative predictive value, and 95% CIs of ROX for invasive mechanical ventilation any time during hospitalization.

SETTING:

Twenty-one hospitals of Kaiser Permanente Northern California, an integrated healthcare delivery system. PATIENTS We identified adults with positive severe acute respiratory syndrome coronavirus 2 polymerase chain reaction test within 3 weeks of, or during, hospitalization between February 1, 2020, and December 31, 2020. We calculated ROX at 12 hours after HFNC initiation. We grouped patients as low (≥ 4.88), intermediate (< 4.88 and ≥ 3.85), or high (< 3.85) risk using previously published thresholds.

INTERVENTIONS:

None. MEASUREMENTS AND MAIN

RESULTS:

We identified 1,847 patients who had no limitation of life support. Of these, 525 (31.7%) received invasive mechanical ventilation any time during hospitalization and 511 died (27.7%). The sensitivity, specificity, positive predictive value, and negative predictive value of 12-hour ROX threshold (< 3.85) predicting invasive mechanical ventilation were 32.3% (95% CI, 28.5-36.3%), 89.8% (95% CI, 88.0-91.4%), 59.4% (95% CI, 53.8-64.9%), and 74.1% (95% CI, 71.8-76.3%), respectively.

CONCLUSIONS:

The 12-hour ROX index has a positive predictive value (59.4%) using threshold of less than 3.85 for COVID-19 patients needing invasive mechanical ventilation. Our health system has embedded ROX into the electronic health record to prioritize rounding during periods of inpatient surge.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Insufficiency / Noninvasive Ventilation / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Adult / Humans Language: English Journal: Crit Care Med Year: 2022 Document Type: Article Affiliation country: CCM.0000000000005474

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Respiratory Insufficiency / Noninvasive Ventilation / COVID-19 Type of study: Cohort study / Observational study / Prognostic study Limits: Adult / Humans Language: English Journal: Crit Care Med Year: 2022 Document Type: Article Affiliation country: CCM.0000000000005474